Altay Therapeutics
altaytherapeutics.com
Biotechnology
Altay Therapeutics is developing the first oral drug for Facioscapulohumeral Muscular Dystrophy (FSHD) and advancing new solutions for cancer treatment. The company focuses on innovative therapies to address unmet medical needs.
Founded
2019
Total Funding
$10M+
Total Rounds
1
First Raise
Oct 14, 2026
Latest Raise
Oct 14, 2026
Get notified when Altay Therapeutics and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/14/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Altay Therapeutics 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free